Quick Answer
AYTU BIOPHARMA, INC reported Total Revenue of $66.38 million for fiscal year 2025.
AYTU BIOPHARMA, INC Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $66.38M | +1.8% |
| 2024 | $65.18M | -39.3% |
| 2023 | $107.40M | +11.1% |
| 2022 | $96.67M | +47.3% |
| 2021 | $65.63M | +137.5% |
| 2020 | $27.63M | +277.5% |
| 2019 | $7.32M | +100.0% |
| 2018 | $3.66M | +13.6% |
| 2017 | $3.22M | +25.7% |
| 2016 | $2.56M | +878.8% |
| 2015 | $261.8K | +344.2% |
| 2014 | $58.9K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $15.16M | -6.5% | +9.2% |
| September 30, 2025 | $13.89M | -16.2% | -24.7% |
| March 31, 2025 | $18.45M | +31.6% | +13.8% |
| December 31, 2024 | $16.22M | -13.5% | -2.1% |
| September 30, 2024 | $16.57M | -7.0% | +18.2% |
| March 31, 2024 | $14.03M | -38.3% | -25.2% |
| December 31, 2023 | $18.75M | -28.7% | +5.2% |
| September 30, 2023 | $17.82M | -35.6% | -21.6% |
- AYTU BIOPHARMA, INC showed an increase of +1.8% in Total Revenue compared to the prior fiscal year.
- Over the 2014–2025 period, AYTU BIOPHARMA, INC’s total revenue has grown by 112547.4% (from $58.9 thousand to $66.38 million).
- The most recent figure is from AYTU BIOPHARMA, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 23, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: